Elmwood Wealth Management Inc. Decreases Holdings in UnitedHealth Group Incorporated $UNH

Elmwood Wealth Management Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,388 shares of the healthcare conglomerate’s stock after selling 40 shares during the quarter. Elmwood Wealth Management Inc.’s holdings in UnitedHealth Group were worth $1,681,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in UNH. Nuveen LLC bought a new position in UnitedHealth Group during the 1st quarter valued at about $3,846,764,000. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. National Bank of Canada FI grew its stake in UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after acquiring an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after acquiring an additional 847,054 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have commented on UNH shares. Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Barclays upped their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, KeyCorp upped their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Trading Up 1.2%

NYSE:UNH opened at $358.80 on Tuesday. The firm has a 50 day moving average of $320.57 and a 200 day moving average of $346.99. The stock has a market capitalization of $324.96 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.